Micro penis. Disorder of penis, unspecified
Conditions
Interventions
Intervention 1: Group A: Testosterone enanthate injection 2 mg based on weight every 3 weeks for up to 3 doses based on patient needs (the patient is examined at 3-week intervals and the medication is
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
Male
Age
No minimum to 3 Years
Inclusion criteria
Inclusion criteria: Micropenis without comorbidities (all patients with symptoms of micropenis) Age less than 3 years Diagnosis of micropenis based on the criterion of penile length less than 2.5 standard deviations below the mean for age (with karyotype 46,XY). No history of micropenis treatment Written consent from parents/legal guardians to participate in the study
Exclusion criteria
Exclusion criteria: Gender ambiguity History of anaphylactic shock Infants or children with chromosomal abnormalities or karyotypes other than 46,XY (such as Klinefelter syndrome, gonadal dysgenesis, or other disorders of sex differentiation) Presence of severe hypospadias Chronic or severe systemic diseases (such as advanced heart, kidney, or liver disease). History of sensitivity or severe reaction to testosterone or hCG. Presence of other metabolic or endocrine diseases that affect sexual development (such as hypothyroidism or adrenal disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Width. Timepoint: At the beginning of the study, 3 weeks later, 3 months later, and after the end of the study (6 months later). Method of measurement: Ruler.;Length. Timepoint: At the beginning of the study, 3 weeks later, 3 months later, and after the end of the study (6 months later). Method of measurement: Ruler. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHamed Jabalbarezi
Kerman University of Medical Sciences
Outcome results
None listed